ROCKWELL MEDICAL, INC. Interest Expense Nonoperating
ROCKWELL MEDICAL, INC. (RMTI) reported Interest Expense Nonoperating of $281.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $281.00K, a 1.81% increase year-over-year.
- ROCKWELL MEDICAL, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $282.00K, a 1.81% increase year-over-year.
- ROCKWELL MEDICAL, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $286.00K, a 1.04% decline year-over-year.
- ROCKWELL MEDICAL, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $285.00K, a 5.63% decline year-over-year.
- ROCKWELL MEDICAL, INC. interest expense nonoperating for fiscal 2025 was $1.12M, a 10.37% decline from fiscal 2024.
- ROCKWELL MEDICAL, INC. interest expense nonoperating for fiscal 2024 was $1.25M, a 45.50% decline from fiscal 2023.
- ROCKWELL MEDICAL, INC. interest expense nonoperating for fiscal 2023 was $2.30M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $281.00K 10-Q · filed 2026-08-13 | $563.00K 10-Q · filed 2026-08-13 | $849.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.13M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $282.00K 10-Q · filed 2026-05-07 | $568.00K derived: sum of 2 quarters · filed 2026-05-07 | $853.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.13M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $286.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $571.00K derived: sum of 2 quarters · filed 2026-03-26 | $847.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.12M 10-K · filed 2026-03-26 |
| 2025-09-30 | $285.00K 10-Q · filed 2025-11-12 | $561.00K derived: sum of 2 quarters · filed 2026-08-13 | $838.00K 10-Q · filed 2025-11-12 | $1.13M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $276.00K 10-Q · filed 2026-08-13 | $553.00K 10-Q · filed 2026-08-13 | $842.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.14M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $277.00K 10-Q · filed 2026-05-07 | $566.00K derived: sum of 2 quarters · filed 2026-05-07 | $868.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.10M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $591.00K derived: sum of 2 quarters · filed 2026-03-26 | $823.00K derived: sum of 3 quarters · filed 2026-03-26 | $1.25M 10-K · filed 2026-03-26 |
| 2024-09-30 | $302.00K 10-Q · filed 2025-11-12 | $534.00K derived: sum of 2 quarters · filed 2025-11-12 | $965.00K 10-Q · filed 2025-11-12 | $2.07M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $232.00K 10-Q · filed 2025-08-14 | $663.00K 10-Q · filed 2025-08-14 | $1.77M derived: sum of 3 quarters · filed 2025-08-14 | $2.18M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $431.00K 10-Q · filed 2025-05-12 | $1.54M derived: sum of 2 quarters · filed 2025-05-12 | $1.95M derived: sum of 3 quarters · filed 2025-05-12 | $2.35M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $1.52M derived: sum of 2 quarters · filed 2025-03-20 | $1.91M derived: sum of 3 quarters · filed 2025-03-20 | $2.30M 10-K · filed 2025-03-20 |
| 2023-09-30 | $411.00K 10-Q · filed 2024-11-12 | $806.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.19M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $395.00K 10-Q · filed 2024-08-08 | $782.00K 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |